Corneal Disease Clinical Trials

3 recruiting

Corneal Disease Trials at a Glance

8 actively recruiting trials for corneal disease are listed on ClinicalTrialsFinder across 6 cities in 5 countries. The largest study group is Early Phase 1 with 1 trial, with the heaviest enrollment activity in Anaheim, Athens, and Dresden. Lead sponsors running corneal disease studies include Singapore Eye Research Institute, Hellenic Society of Hematology, and Eye & ENT Hospital of Fudan University.

Browse corneal disease trials by phase

Treatments under study

About Corneal Disease Clinical Trials

Looking for clinical trials for Corneal Disease? There are currently 3 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Corneal Disease trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Corneal Disease clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting

Data Gathering for A10900

HealthyRetinal DiseaseGlaucoma+1 more
Optos, PLC180 enrolled4 locationsNCT07149740
Recruiting
Not Applicable

4D Duke Microscope Integrated Optical Coherence Tomography in a Zeiss Artevo 800

Corneal Diseases
Duke University5 enrolled1 locationNCT07024719
Recruiting

Validation of the Use of Terahertz Scanning System on Corneal Scars and Corneal Edema

Corneal DiseasesCorneal EdemaCorneal Scars and Opacities
Singapore Eye Research Institute150 enrolled1 locationNCT06983652
Recruiting

Evaluation of the Safety of Terahertz Scanning System on Corneas

Corneal Diseases
Singapore Eye Research Institute5 enrolled1 locationNCT06967792
Recruiting

Artificial Intelligence for Screening of Multiple Corneal Diseases

ScreeningDeep LearningCorneal Disease
Tianjin Eye Hospital3,000 enrolled1 locationNCT06211218
Recruiting
Early Phase 1

Novel Antisense Oligonucleotide Eye Drops for Treating Antibiotic-Resistant Bacterial Keratitis

Bacterial KeratitisSensation DisordersInfections, Bacterial+7 more
Eye & ENT Hospital of Fudan University20 enrolled1 locationNCT06451172
Recruiting
Phase 1Phase 2

A Study to Investigate Safety and Clinical Activity of Belantamab Mafodotin in Combination With Lenalidomide, Dexamethasone and Nirogacestat in Patients With Transplant Ineligible Newly Diagnosed Multiple Myeloma

NeoplasmsMultiple MyelomaParaproteinemias+5 more
Hellenic Society of Hematology36 enrolled2 locationsNCT05573802
Recruiting

Dresden Corneal Disease and Treatment Study

Corneal EctasiaCorneal Disease
Technische Universität Dresden700 enrolled1 locationNCT04251143